Globe Newswire

CALGARY, Alberta, June 10, 2024 (GLOBE NEWSWIRE) -- Canoe Financial LP (“Canoe Financial”) today announced unitholder approval to proceed with changes to Canoe Premium Income Fund (the “Fund”) as previously announced on March 28, 2024. Canoe Financial also announced a change in sub-advisor for Canoe Global Income Fund and Canoe Global Income Portfolio Class (collectively, “Global Income Funds”).

Changes to Canoe Premium Income Fund

Effective after the close of... (continue reading...)

HOUSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that its Board of Trustees has declared a monthly cash dividend of $0.04125 per share on the Company's common shares and operating partnership units for the third quarter of 2024. The dividend represents a quarterly amount of $0.12375 per share, and an annualized amount of $0.495 per share.

The third quarter dividend distribution for 2024 will be as... (continue reading...)

NHL and Rogers to Co-Host Free Concerts Outside Rogers Place Before Game 3 & 4

Rogers Holding National Customer Contest for Stanley Cup Final

EDMONTON, Alberta, June 10, 2024 (GLOBE NEWSWIRE) -- The National Hockey League (NHL) and Rogers today announced plans for the Rogers Festival at the Final concert series to celebrate the 2024 Stanley Cup Final between the Edmonton Oilers and Florida Panthers. Global superstar and five-time GRAMMY winner Shania Twain and... (continue reading...)

ISELIN, N.J., June 10, 2024 (GLOBE NEWSWIRE) -- Middlesex Water Company (NASDAQ: MSEX) has named Mohammed G. (Rally) Zerhouni as its new Senior Vice President, Chief Financial Officer and Treasurer effective June 24, 2024, as part of its ongoing strategic succession planning efforts. Zerhouni joins Middlesex following a comprehensive search for a successor to Senior Vice President, Treasurer and Chief Financial Officer, A. Bruce O’Connor, who will retire from the... (continue reading...)

WINSTON-SALEM, N.C., June 10, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, today announced that it has commenced an underwritten public offering and a concurrent registered direct offering of up to an aggregate of $125 million of its Class A ordinary shares, before deducting underwriting discounts and commissions and other offering... (continue reading...)